SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ICOS Corporation

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Brasco One who wrote (887)5/1/2002 4:06:38 PM
From: Edscharp  Read Replies (1) of 1139
 
LOL! I kind of agree with you. IMO, ICOS has been way over priced for a long time. Nonetheless, yesterday I bought into ICOS at @25.50/share.

The fact is that the news isn't that bad. ICOS will have to do some additional clinical tests, but there do not appear to be any safety or efficacy issues.

Yes, even at $25.50 this stock is overpriced, but historically the market has always kept this stock's valuation in the stratosphere. It all has to do with trying to emulate Bill Gates' investment portfolio.

Even though it deserves to be in the teens I don't believe it will get anywhere near that.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext